According to a new study conducted by researchers at University of Michigan Medical School and published in the journal Cell, a drug which was originally formulated to stop cancer growth may be capable of halting abnormal brain cells from growing in childrens' brains - which could reduce the risk of learning disabilities. This new evidence has researchers wondering if anti-tumor drugs could possibly protect kid's brain who have neurofibromatosis 1 and other learning disabilities during the key developmental stage. Neurofibromatosis 1 (NF1) is present in 1 in every 3,000 kids...
Fonte: healthnews.com
Indique esta NotÃcia
Compartilhar
A PHP Error was encountered
Severity: User Warning
Message: Smarty error: unable to read resource: "indiquemat_healthnews.tpl"
Filename: libs/Smarty.class.php
Line Number: 1095
